Companies

the Google DeepMind spin-out commercializing AlphaFold 3; in May 2026 it expanded drug-discovery alliances with Eli Lilly and Novartis valued at around USD 3 billion.

its MAN B&W ME-LGIM two-stroke methanol engine is the industry standard; the 12G95ME-C10.5-LGIM, rated at 82,440 kW at 80 rpm and delivered in June 2025, is the world's most powerful methanol engine, with 230+ references and 600,000+ running hours on methanol.

a US cryo-EM CRO providing structure determination and lipid-nanoparticle characterization for drug discovery under ISO 9001 / GLP quality systems.

operates one of Asia's largest long-read factories, running dozens of PacBio Revio and ONT PromethION systems for plant, animal and human de novo genome services.

OCI HyFuels bio-methanol is supplied to X-Press Feeders and bunkered at Rotterdam and Singapore, delivered by the Chicago methanol bunker barge; FuelEU Maritime plus EU ETS Maritime drive demand.

a carbon-negative materials company founded in 2008 whose chloromethylfurfural (CMF) platform converts lignocellulosic wood residue into PET, chemicals and carbon black; its Origin 1 plant in Sarnia, Ontario has demonstrated commercial-scale conversion of wood feedstock into sustainable intermediates.

the Revio, Onso and Vega long-read systems; its new SPRQ-Nx chemistry, shipping in 2026, brings HiFi whole-human genomes below USD 300 each, enabling large cohort projects.

PETase/MHETase research — Ideonella sakaiensis enzyme engineering.

its Biopure platform uses AI-designed enzymes to depolymerize polyester waste, and an expanded collaboration with Basecamp Research targets polyurethane and nylon recycling, with partners including ESPCI Paris, JBEI and Fashion for Good.

premium SBDD CROs offering cryo-EM, fragment screening and ligand-affinity analysis under EU quality systems; Proteros collaborates with Axcelead to serve Japanese clients.

the S-Trap sample-preparation technology (including 96-well micro plates) that standardizes digestion and lowers run-to-run variability.

operates one of the largest robotic phenotypic-screening facilities for lab-in-the-loop data generation (Recursion OS); it combined with Exscientia in November 2024 to form an end-to-end AI discovery company.

the standard for physics-based FEP+ software used across big pharma for binding-affinity prediction and lead optimization.

a national infrastructure whose Clinical Genomics unit delivers long-read diagnostics, contributing to the European Pangenome Consortium.

the SomaScan aptamer platform; its SomaScan Select 4K assay quantifies around 4,000 proteins from a small plasma sample.

cheap inorganic sorbents with thermostable enzymes plus direct electric heating, reporting 90%+ energy efficiency and a path to removal below USD 100 per tonne — over three times cheaper than prevailing DAC.

the 31DF gas engine's new version cuts methane emissions by an average 41% versus the previous market best, and the 25DF with NextDF holds methane slip below 1.1% of fuel use.

a top-tier CRO whose Structure Biology Division integrates cryo-EM into its compound-library screening services for global clients.

the Estonian Äio (a Tallinn University of Technology spin-off that won a $1.4 million government grant and a €1.2 million scale-up grant for wood- and dairy-sidestream fats) and Sweden's Melt&Marble (precision-fermentation designer fats) extend the European field across the Baltics and Nordics.

the New York pioneer whose Palmless platform makes yeast-fermented oils and fats, backed by Breakthrough Energy Ventures and with an FDA GRAS determination that opens the route to US food-industry integration alongside its cosmetic B2B sales.

pioneer of CNC structural color and roll-to-roll printing of cellulose photonic films, including biodegradable structural-color pigments and anticounterfeiting patterns.

a Beijing research leader advancing solid-state fermentation of okara with Aspergillus oryzae and lactic-acid bacteria to remove the beany off-flavour and convert soy pulp into functional fibre and protein for noodles and baked goods.

a UK developer of yeast-oil palm alternatives that secured £4.5 million ($6.1 million) in funding plus a £0.7 million Innovate UK grant to scale toward UK Novel Food validation.

the largest US producer of decorative interior plywood, whose PureBond line uses Soyad to ship more than 100 million formaldehyde-free panels, sharply improving indoor-air quality in American homes.

77,000 t/yr bio-PDO from regenerative Midwestern corn, processed in Loudon, TN — 86% lower carbon footprint (4.41 kg CO2 eq) than fossil PDO, 20 years in market.

the €8.4 M EU-funded Bio4PURConti project (June 2026) targets the world's first continuous bio-based aniline process for MDI, cutting up to ~20 Mt/yr of global fossil-aniline CO2; Desmopan EC TPU carries up to 60% biomass carbon (>20% lower footprint).

a Chinese Academy of Sciences institute advancing heterotrophic microalgae strains that convert cheap industrial glycerol — a biodiesel by-product — into microbial lipids, with demonstration-plant work in Guangdong.

castor bio-polyols (Vithal Castor Polyols) — 90% VCPL stake (2026), NSE:JAYAGROGN.

a Danish company upcycling spent coffee grounds into KAFFOIL coffee-oil ingredients, whose KLEANSTANT bio-based surfactant won a 2025 industry award for converting coffee oil into a natural anionic surfactant.

the Estonian Äio (a Tallinn University of Technology spin-off that won a $1.4 million government grant and a €1.2 million scale-up grant for wood- and dairy-sidestream fats) and Sweden's Melt&Marble (precision-fermentation designer fats) extend the European field across the Baltics and Nordics.

DURABIO (isosorbide bio-PC) — low birefringence, high transmission, scratch-resistant.

a Pennsylvania company that commercialised poly(catechol-styrene) mussel-mimetic chemistry in its SeaTak adhesive, which bonds concrete, metals and composites underwater, completing a US DoD Phase 1 contract for at-sea hull repair and raising seed funding in March 2026 to build a pilot plant.

a Colorado fungi-fermentation firm producing ClearIQ bitter-blocking and mycelium-based ingredients from solid-state fermentation of agricultural streams, having refined its portfolio around taste and clean-label function.

a Wageningen company fermenting potato peels, sugar-beet waste and brewer's spent grain with yeast into palm-free oil, scaling through a demonstration-factory agreement with the NIZO food research institute.

the laboratory of Kaichang Li that invented the soy-adhesive mechanism and pioneered mussel-protein-inspired adhesion, anchoring the science the industry now runs on.

the B2B brand of Upcycled Foods, Inc., whose patented rapid dehydration turns wet brewer's spent grain into SuperGrain+ flour supplied to pasta, chip and bread makers.

an Oakland company that dries and micronises okara from soymilk plants into a gluten-free, high-protein, high-fibre flour, extending the line to oat-pulp ingredients sold B2B and as baking mixes under the Upcycled Certified mark.

a Dutch startup that physically fractionates spent brewer's yeast — sourced in partnership with AB InBev — into protein and beta-glucan ingredients that replace egg white and methylcellulose in plant-based meats and baking, with a commercial plant in the Netherlands.

a Chinese Academy of Sciences institute leading the computational design of high-yield recombinant spidroins for bioinspired fibers, including hybrid threads reinforced with graphene oxide that exceed 2 gigapascals in tensile strength.

the US chemical group that commercialised the Soyad soy-adhesive system (licensed from Oregon State University), combining soy flour with a PAE crosslinker to let interior plywood fully abandon urea-formaldehyde resins.

the Japanese firm whose Brewed Protein fibers — brewed by microbes from plant sugars at its roughly 500-tonne-per-year Rayong plant in Thailand — supply Asian apparel leaders such as Goldwin and The North Face, anchoring the region's commercial scale.

the laboratory of Randy Lewis, the world's leading academic authority on spider-silk genetics, which first decoded the spidroin genes, built transgenic goat and moss platforms, and set the wet-spinning methods the industry now uses.

the F3 — Films for Future platform (with LUT University) has reached pilot-scale 100% cellulose transparent films and coatings (by March 2026) for packaging and flexible bio-electronics.

Anika is a global leader in osteoarthritis pain management and early-intervention regenerative orthopedics, reporting full-year 2025 results with HA-based viscosupplementation (Monovisc, Cingal) for knee osteoarthritis.

a Hong Kong cultivated-seafood company growing grouper, snapper and eel cells in a Singapore pilot plant, which had planned a 30-fold capacity expansion; it is restructuring its Singapore operations while continuing to pursue regulatory approval in the city-state.

BD Biosciences runs the Rhapsody multi-omics platform, and Mission Bio's Tapestri reads somatic DNA mutations and proteins per cell, used to monitor leukaemia therapy.

MIT-alumni founded startup (2017, $91.5M total funding across 15 rounds, ~$20M annual revenue) running the national Biobot Portal; awarded the White House ONDCP contract in January 2026 to deliver nationwide substance-use intelligence across more than 20 chemical targets, building on its 2020–2024 NIDA SBIR programme.

Blackrock's Utah Array underpins the BrainGate program — the longest-running human BCI program — with a published decade of intracortical-microstimulation safety, while Precision Neuroscience received FDA 510(k) clearance for its 1,024-channel Layer 7 cortical interface in April 2025.

the San Diego developer of a non-GMO fish-cell-propagation platform for premium bluefin tuna toro, which has raised roughly $129 million (including a recent $11 million round) from Agronomics, Siddhi Capital, Lewis & Clark AgriFood and about 40 strategic food-industry investors.

PeptiStrong became a premium recovery ingredient and a sarcopenia-prevention nutraceutical for ageing adults, while Brightseed scaled Forager-discovered phytonutrients with healthy-food brand partners.

peptide supplements — finished functional nutrition formats.

the US food conglomerate runs food- and cosmetic-grade marine collagen lines, sourcing and processing wild cold-water fish skins into soluble premixes for American beauty-and-health brands.

Celmatix's Resolve platform uses multi-omic and clinical big data to map ovarian reserve and design non-hormonal candidates against ovarian ageing, and Hungarian pharma Gedeon Richter has acquired Celmatix's women's-health drug-discovery portfolio spanning fertility and endometriosis programs.

the China CDC Institute of Environmental Health convened a 15-city multi-pathogen sewage surveillance seminar in Zhuhai (November 2025) with 50 experts, and field-validated provincial rollout in Shaanxi (Xi'an, Baoji, Yulin, Ankang), targeting cholera, typhoid and respiratory pathogens.

the largest environmental-protection operator in China runs regional straw-densification hubs and biomass combined-heat-and-power plants that anchor the country's waste-to-energy reverse-logistics network.

EFSA runs multi-year safety testing of bioactive marine peptides before clearing them as Novel Foods, checking allergenic potential and molecular-profile stability, while Copalis (France) supplies specialized wild-fish hydrolysates (Alphamine, Collactive) as a B2B ingredient partner.

Italian Fidia won FDA approval for HYMOVIS ONE, a single-injection hyaluronan therapy for knee osteoarthritis launched at AAOS 2026, and runs the established Hyalgan viscosupplementation line, while EU R&D develops HA–recombinant-collagen combination implants for tissue regeneration.

a Berkeley pioneer developing sushi-grade cultivated Pacific bluefin tuna, financing its 2025 launch pathway through regulated investment crowdfunding alongside ongoing institutional backing.

German and Austrian startups (e.g. Fooditive in the wider EU fermentation cluster) work on reconstructing unique monofloral profiles such as alpine wildflower honey via fine phytochemical extraction.

Galderma, the pure-play dermatology category leader, delivered record 2025 net sales of $5.21 billion (up 17.7% constant currency) with core EBITDA of $1.21 billion, anchored by the Restylane cross-linked HA filler line.